Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-06 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | ATOX1 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-06 |
mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | NBPF14 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | FKBP10 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | UBTD1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
mRNA | AP003419.11 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | C11orf24 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |